Business Context and Reporting Period
This Form 8-K filing by HealthEquity, Inc. (HQY) reports a material corporate event dated April 6, 2026. The filing addresses the departure of a senior executive and the subsequent appointment of an interim leader for the technology organization.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Executive Departure: Eli Rosner, Chief Technology Officer (CTO), will be terminated without cause, effective April 17, 2026.
- Interim Leadership: Sunil Rajasekar, Executive Vice President, Chief Product and Strategy Officer, will assume oversight of the technology organization effective April 17, 2026.
Guidance, Outlook, and Management Commentary
Severance and Compensation: Mr. Rosner will receive previously negotiated severance payments and benefits as detailed in the Company's proxy statement filed on May 13, 2025, contingent upon the execution of a release of claims and compliance with restrictive covenants. His outstanding equity awards will be treated consistent with the 2014 and 2024 Stock Incentive Plans.
Successor Background: Mr. Rajasekar joined HealthEquity in January 2026. His prior experience includes serving as CEO of Billtrust (2022–2025), President of MINDBODY (2018–2022), and senior roles at eBay, Lithium Technologies (Khoros), Intuit, Cisco, and Oracle.
The filing does not provide specific forward-looking guidance, risk factors, or commentary on unusual items beyond the executive transition.
Investor Verification Checklist
- Verify the specific severance amount and equity treatment details in the proxy statement filed on May 13, 2025.
- Confirm the effective date of the CTO transition (April 17, 2026) and any potential impact on ongoing technology projects.
- Review the Company's most recent quarterly or annual report for the latest financial performance metrics, as this 8-K contains none.